首页 > 最新文献

International journal of pharmacy and pharmaceutical research最新文献

英文 中文
A Review of Diagnostic Techniques for Parkinson’s Disease 帕金森病诊断技术综述
Pub Date : 2022-06-30 DOI: 10.25166/ijppr/2022.24.3.1
Vanita G. Kanse, Megh M. Thosar
Parkinson's disease is the second most common progressive neurodegenerative disorder in older people. Idiopathic Parkinson's Disease is associated with risk factors such as aging, family history, pesticide exposure, and environmental chemicals (e.g., synthetic heroin use). It is caused by a pathophysiologic loss or degeneration of dopaminergic neurons in the substantia nigra of the midbrain and the development of neuronal Lewy Bodies. Its underlying causes are unknown. Despite significant advances in neurodegenerative disease research since James Parkinson's first medical description of Parkinson's disease in 1817, these disorders continue to pose significant diagnostic and treatment challenges. A valid diagnosis at early disease stages is critical because it can help accommodate differential prognostic and disease management approaches, elucidate reliable clinicopathological relationships ideally at prodromal stages, and would make it easier to evaluate innovative treatments in clinical trials. The pursuit of early diagnosis in Parkinson's disease and atypical Parkinsonian syndromes, however, is hampered by significant clinical and pathological heterogeneity, which can affect disease presentation and progression. Therefore, more accurate more specific diagnostic techniques are required to differentiate Parkinson’s disease from other neurological conditions.
帕金森病是老年人中第二常见的进行性神经退行性疾病。特发性帕金森病与衰老、家族史、农药暴露和环境化学物质(如使用合成海洛因)等风险因素有关。它是由中脑黑质多巴胺能神经元的病理生理损失或变性以及神经元路易体的发育引起的。其根本原因尚不清楚。尽管自1817年詹姆斯·帕金森首次对帕金森病进行医学描述以来,神经退行性疾病研究取得了重大进展,但这些疾病仍对诊断和治疗构成重大挑战。在疾病早期阶段进行有效诊断至关重要,因为它有助于适应不同的预后和疾病管理方法,阐明可靠的临床病理关系,最好是在前驱期,并使临床试验中更容易评估创新治疗方法。然而,帕金森病和非典型帕金森综合征的早期诊断受到显著的临床和病理异质性的阻碍,这可能会影响疾病的表现和进展。因此,需要更准确、更具体的诊断技术来区分帕金森病和其他神经疾病。
{"title":"A Review of Diagnostic Techniques for Parkinson’s Disease","authors":"Vanita G. Kanse, Megh M. Thosar","doi":"10.25166/ijppr/2022.24.3.1","DOIUrl":"https://doi.org/10.25166/ijppr/2022.24.3.1","url":null,"abstract":"Parkinson's disease is the second most common progressive neurodegenerative disorder in older people. Idiopathic Parkinson's Disease is associated with risk factors such as aging, family history, pesticide exposure, and environmental chemicals (e.g., synthetic heroin use). It is caused by a pathophysiologic loss or degeneration of dopaminergic neurons in the substantia nigra of the midbrain and the development of neuronal Lewy Bodies. Its underlying causes are unknown. Despite significant advances in neurodegenerative disease research since James Parkinson's first medical description of Parkinson's disease in 1817, these disorders continue to pose significant diagnostic and treatment challenges. A valid diagnosis at early disease stages is critical because it can help accommodate differential prognostic and disease management approaches, elucidate reliable clinicopathological relationships ideally at prodromal stages, and would make it easier to evaluate innovative treatments in clinical trials. The pursuit of early diagnosis in Parkinson's disease and atypical Parkinsonian syndromes, however, is hampered by significant clinical and pathological heterogeneity, which can affect disease presentation and progression. Therefore, more accurate more specific diagnostic techniques are required to differentiate Parkinson’s disease from other neurological conditions.","PeriodicalId":92533,"journal":{"name":"International journal of pharmacy and pharmaceutical research","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43574113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conceptual Review of Pravala (Coral) – A Marine Source of Natural Calcium 普拉瓦拉(珊瑚)-天然钙的海洋来源的概念综述
Pub Date : 2022-02-28 DOI: 10.25166/ijppr/2022.23.3.1
Geeta G. Gadad, Vikram Singh, B. Sundar
Background: Pravala (Coral) is one among the nine ratnas (precious stones), as categorized by all the texts of Rasashastra. Pravala is widely used in ayurvedic practice being a rich source of natural calcium and various trace elements. Objective: To critically review and highlight potential natural sources of calcium:pravala from classical and contemporary literature with recent research works. Data source: Ancient Indian literature, Classical texts of Rasa shastra from Rasa Hridaya Tantra (9th Cent. A.D) to Rasa Tarangini (20th Cent. A.D). Materials and Methods: Present work has reviewed and compiled a detailed description of Pravalaparyaya (synonyms), utpatti (Occurrence), bheda (types), grahya/agrahya laxanas (Considerable/Nonconsiderable properties for medicinal preparations), guna karma (Pharmacological and therapeutic properties), shodhana (Purification), Marana (Incineration), pishtikalpana (fine powder), matra (Dose) amayika prayoga (Therapeutic utility) and Yogas (Compound formulations) with its contemporary science relevance. Result: Data from the critical review of classical and contemporary research works. Conclusion: Pravala being natural source of calcium, is administered in the form of Bhasma (Calyx) and Pishti (Paste)for curing ailments such as Amlapitta (Hyperacidity), Netra Roga (Eye diseases), and Hridaya Roga (Cardiac diseases). Pravala is having pitta shamaka (Soothing effect) and Asthiposhaka (Bone mineralization) properties ideally indicated to treat mainly disorders of pitta aggravation and asthikshaya (Calcium deficiency).
背景:普拉瓦拉(珊瑚)是九种宝石(宝石)之一,被《罗萨沙斯特拉》的所有文本分类。普拉瓦拉作为天然钙和各种微量元素的丰富来源,在阿育吠陀实践中被广泛使用。目的:结合近期的研究成果,从古典和当代文献中批判性地回顾和突出潜在的天然钙来源:普拉瓦拉。资料来源:古印度文献,Rasa shastra的经典文本,从Rasa Hridaya Tantra(公元9世纪)到Rasa Tarangini(公元20世纪)。材料与方法:目前的工作已经回顾和汇编了Pravalaparyaya(同义词)、utpatti(发生)、bheda(类型)、grahya/agrahya laxanas(药物制剂的可观/不可观特性)、guna karma(药理和治疗特性)、shodhana(净化)、Marana(焚烧)、pishtikalpana(细粉)、matra(剂量)amayika prayoga(治疗效用)和Yogas(复合配方)及其当代科学相关性的详细描述。结果:数据来源于对古典和当代研究著作的批判性回顾。结论:Pravala是钙的天然来源,以Bhasma(花萼)和Pishti(膏状)的形式给药,用于治疗Amlapitta(高酸性)、Netra Roga(眼病)和Hridaya Roga(心脏病)等疾病。Pravala具有镇静作用(pitta shamaka)和骨矿化(Asthiposhaka)特性,主要用于治疗pitta加重和asthikshaya(钙缺乏症)。
{"title":"Conceptual Review of Pravala (Coral) – A Marine Source of Natural Calcium","authors":"Geeta G. Gadad, Vikram Singh, B. Sundar","doi":"10.25166/ijppr/2022.23.3.1","DOIUrl":"https://doi.org/10.25166/ijppr/2022.23.3.1","url":null,"abstract":"Background: Pravala (Coral) is one among the nine ratnas (precious stones), as categorized by all the texts of Rasashastra. Pravala is widely used in ayurvedic practice being a rich source of natural calcium and various trace elements. Objective: To critically review and highlight potential natural sources of calcium:pravala from classical and contemporary literature with recent research works. Data source: Ancient Indian literature, Classical texts of Rasa shastra from Rasa Hridaya Tantra (9th Cent. A.D) to Rasa Tarangini (20th Cent. A.D). Materials and Methods: Present work has reviewed and compiled a detailed description of Pravalaparyaya (synonyms), utpatti (Occurrence), bheda (types), grahya/agrahya laxanas (Considerable/Nonconsiderable properties for medicinal preparations), guna karma (Pharmacological and therapeutic properties), shodhana (Purification), Marana (Incineration), pishtikalpana (fine powder), matra (Dose) amayika prayoga (Therapeutic utility) and Yogas (Compound formulations) with its contemporary science relevance. Result: Data from the critical review of classical and contemporary research works. Conclusion: Pravala being natural source of calcium, is administered in the form of Bhasma (Calyx) and Pishti (Paste)for curing ailments such as Amlapitta (Hyperacidity), Netra Roga (Eye diseases), and Hridaya Roga (Cardiac diseases). Pravala is having pitta shamaka (Soothing effect) and Asthiposhaka (Bone mineralization) properties ideally indicated to treat mainly disorders of pitta aggravation and asthikshaya (Calcium deficiency).","PeriodicalId":92533,"journal":{"name":"International journal of pharmacy and pharmaceutical research","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69237916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Assessment of Structural Changes in Vankshan Sandhi Hip Joint with Respect to Avascular Necrosis in Sickle Cell Anemia A Prospective Observational Study 镰状细胞性贫血中Vankshan Sandhi髋关节结构改变与缺血性坏死的临床评估:一项前瞻性观察研究
Pub Date : 2022-01-01 DOI: 10.25166/ijppr.2022.25.1.6
P. Thakare, Sudam L. Kate, Girish T. Kulkarni, M. Suryawanshi, S. Jadhav
{"title":"Clinical Assessment of Structural Changes in Vankshan Sandhi Hip Joint with Respect to Avascular Necrosis in Sickle Cell Anemia A Prospective Observational Study","authors":"P. Thakare, Sudam L. Kate, Girish T. Kulkarni, M. Suryawanshi, S. Jadhav","doi":"10.25166/ijppr.2022.25.1.6","DOIUrl":"https://doi.org/10.25166/ijppr.2022.25.1.6","url":null,"abstract":"","PeriodicalId":92533,"journal":{"name":"International journal of pharmacy and pharmaceutical research","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69237454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Critical Analysis of Formulation andProbable Mode of Action of Avipattikara churna: A Comprehensive Review 油桐制剂及其可能作用方式的批判性分析——综述
Pub Date : 2021-09-30 DOI: 10.25166/ijppr/2021.22.2.1
Geeta G. Gadad, K. S. Gudaganatti
Background: The mode of action of a compound Ayurvedic formulation is a critical and essential issue to be concentrated in assuring the therapeutic efficacy and safety based on its composition. Avipattikara Churna is one of the commonly used formulations containing herbs-mineral drugs. Objective: To emphasize the rationality of Avipattikara Churna and its mode of action by classical and contemporary review. Data Source: Classical texts like Vangasena Samhita, Bhaishajya Ratnavali, Rasendra Sara sangraha, Rasendra Chintamani, and published research works. Material and Methods: In the present study a critical analysis based on ingredients and probable mode of action of Avipattikara Churna in different indicated clinical conditions like agnimandya (digestive impairment), vibandha (constipation), amlapitta (hyperacidity), arsha (piles), mutraghata (retention of urine) and prameha (diabetes mellitus) were done based on classical and contemporary research works. Result: Data from the critical review of classical and contemporary research works. Conclusion: Avipattikara Churna is a versatile formulation used in a wide range of gastrointestinal disorders. By this review, it can be emphasized that Avipattikara Churna, which is in clinical practice for Amlapitta (Hyperacidity) and vibandha (constipation) is a tailored formula by its ingredients. In-vivo studies not only justify the effectiveness of the formulation but provide more evidence of the safety and efficacy of the formulation. Clinical research works substantiate its significant gastroprotective activity.
背景:复方阿育吠陀制剂的作用模式是一个关键和重要的问题,需要根据其成分来集中确保治疗效果和安全性。Avipattikara Churna是一种常用的含有草药和矿物药物的配方。目的:通过经典与现代的回顾,强调丘尔纳的合理性及其行动方式。数据来源:Vangasena Samhita、Bhaishajya Ratnavali、Rasendra Sara sangraha、Rasendara Chintamani等经典文本以及已发表的研究著作。材料和方法:在本研究中,根据Avipattikara Churna的成分和可能的作用模式,对不同的临床症状进行了批判性分析,如agnimandya(消化障碍)、vibandha(便秘)、amlapita(胃酸过多)、arsha(痔疮),mutraghata(尿潴留)和prameha(糖尿病)是在经典和现代研究工作的基础上进行的。结果:数据来源于对古典和当代研究著作的批判性评论。结论:Avipattikara Churna是一种用于多种胃肠道疾病的多功能制剂。通过这篇综述,可以强调的是,Avipattikara Churna在Amlapitta(高酸度)和vibandha(便秘)的临床实践中是一种根据其成分量身定制的配方。体内研究不仅证明了该制剂的有效性,而且为该制剂的安全性和有效性提供了更多证据。临床研究工作证实了其显著的胃保护作用。
{"title":"Critical Analysis of Formulation andProbable Mode of Action of Avipattikara churna: A Comprehensive Review","authors":"Geeta G. Gadad, K. S. Gudaganatti","doi":"10.25166/ijppr/2021.22.2.1","DOIUrl":"https://doi.org/10.25166/ijppr/2021.22.2.1","url":null,"abstract":"Background: The mode of action of a compound Ayurvedic formulation is a critical and essential issue to be concentrated in assuring the therapeutic efficacy and safety based on its composition. Avipattikara Churna is one of the commonly used formulations containing herbs-mineral drugs. Objective: To emphasize the rationality of Avipattikara Churna and its mode of action by classical and contemporary review. Data Source: Classical texts like Vangasena Samhita, Bhaishajya Ratnavali, Rasendra Sara sangraha, Rasendra Chintamani, and published research works. Material and Methods: In the present study a critical analysis based on ingredients and probable mode of action of Avipattikara Churna in different indicated clinical conditions like agnimandya (digestive impairment), vibandha (constipation), amlapitta (hyperacidity), arsha (piles), mutraghata (retention of urine) and prameha (diabetes mellitus) were done based on classical and contemporary research works. Result: Data from the critical review of classical and contemporary research works. Conclusion: Avipattikara Churna is a versatile formulation used in a wide range of gastrointestinal disorders. By this review, it can be emphasized that Avipattikara Churna, which is in clinical practice for Amlapitta (Hyperacidity) and vibandha (constipation) is a tailored formula by its ingredients. In-vivo studies not only justify the effectiveness of the formulation but provide more evidence of the safety and efficacy of the formulation. Clinical research works substantiate its significant gastroprotective activity.","PeriodicalId":92533,"journal":{"name":"International journal of pharmacy and pharmaceutical research","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47525947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Design and Optimization of Novel Vaginal Microsphere Gel of Clotrimazole 新型氯三唑阴道微球凝胶的设计与优化
Pub Date : 2021-09-30 DOI: 10.25166/ijppr.2021.v22i02.38
Snehal Bhabad, Snehal Bhabad .
The objective of the study was to develop and evaluatesustained release microsphere gel for the drug clotrimazoleto be administered through the vaginal route. The effect ofpolymer ethylcellulose and carbopol 934 on entrapmentefficiency and diffusion behavior were investigatedrespectively. A 32 full-factorial design was used to optimizethe formulation of Microsphere gel. Microspheres werecharacterized by SEM, FTIR, Entrapment efficiency, andparticle size. Gels were evaluated for in-vitro drug release insimulated vaginal fluid. The microsphere loaded withclotrimazole in bioadhesive carbopol gel formulation wasevaluated for various physicochemical studies and wasfound to be satisfactory. The rheological profile shows thegel formation at desired condition. It is evaluated forspreadability, drug content, In-vitro drug diffusion, stabilitystudy, and bioadhesive study. It may be concluded thatspray drying is a suitable method for microspherepreparation and microsphere gel can be used as a noveldrug delivery system to prolonge release of clotrimazole forvaginal candidiasis.
本研究的目的是开发和评价药物克霉唑经阴道给药的缓释微球凝胶。研究了聚合乙基纤维素和卡波姆934对包埋效率和扩散行为的影响。采用32全因子设计优化微球凝胶的配方。用扫描电镜、红外光谱、包埋效率和颗粒尺寸对微球进行了表征。评估凝胶在体外药物释放的模拟阴道液。对生物粘附卡波姆凝胶制剂中负载克霉唑的微球进行了各种物理化学研究,结果令人满意。流变剖面显示了在所需条件下的凝胶形成。对其传播性、药物含量、体外药物扩散性、稳定性和生物粘附性进行了评价。结果表明,喷雾干燥是一种合适的微球制备方法,微球凝胶可作为一种新型的药物递送系统,延长克霉唑对阴道念珠菌感染的释放。
{"title":"Design and Optimization of Novel Vaginal Microsphere Gel of Clotrimazole","authors":"Snehal Bhabad, Snehal Bhabad .","doi":"10.25166/ijppr.2021.v22i02.38","DOIUrl":"https://doi.org/10.25166/ijppr.2021.v22i02.38","url":null,"abstract":"The objective of the study was to develop and evaluate\u0000sustained release microsphere gel for the drug clotrimazole\u0000to be administered through the vaginal route. The effect of\u0000polymer ethylcellulose and carbopol 934 on entrapment\u0000efficiency and diffusion behavior were investigated\u0000respectively. A 32 full-factorial design was used to optimize\u0000the formulation of Microsphere gel. Microspheres were\u0000characterized by SEM, FTIR, Entrapment efficiency, and\u0000particle size. Gels were evaluated for in-vitro drug release in\u0000simulated vaginal fluid. The microsphere loaded with\u0000clotrimazole in bioadhesive carbopol gel formulation was\u0000evaluated for various physicochemical studies and was\u0000found to be satisfactory. The rheological profile shows the\u0000gel formation at desired condition. It is evaluated for\u0000spreadability, drug content, In-vitro drug diffusion, stability\u0000study, and bioadhesive study. It may be concluded that\u0000spray drying is a suitable method for microsphere\u0000preparation and microsphere gel can be used as a novel\u0000drug delivery system to prolonge release of clotrimazole for\u0000vaginal candidiasis.","PeriodicalId":92533,"journal":{"name":"International journal of pharmacy and pharmaceutical research","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46264501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Comprehensive Review on Anti-Inflammatory Activity of The Traditional Plants Plumbago zeylanica(Chitra) 传统植物白花梧桐抗炎活性研究综述
Pub Date : 2021-08-30 DOI: 10.25166/ijppr.2021.v22i01.14
A. Yadav, Avadh Biharee, Ramesh Kumar, Patel, L. Chaudhari, Dheeraj Dubey
Medicinal plants have long been utilised as a source ofmedicine and are in high demand throughout the world.They've been around for a long time, and they've beenutilised to cure and prevent ailments. Plumbago zeylanica isa medicinal plant that is frequently utilised for its medicinalproperties. It contains several bioactive compounds likenapthoquinones, flavonoids, alkaloids, glycosides, steroids,tri-terpenoids, tannins, fixed oils, fats, proteins, etc. amongall plumbagin is most important bioactive compounds. Itpossesses wide range of pharmaceutical activities such asanti-inflammatory, antimicrobial, anti-cancer, anti-ulcer,antidiabetic etc. Several investigations on itspharmacological activity have been conducted. The goal ofthis review is to provide a comprehensive understanding ofP. zeylanica's chemical composition and pharmacologicalaction.
药用植物长期以来一直被用作药物的来源,在世界各地都有很高的需求。它们已经存在了很长一段时间,它们被用来治疗和预防疾病。白花苜蓿是一种药用植物,因其药用特性而经常被使用。它含有萘醌类、黄酮类、生物碱类、糖苷类、甾体类、三萜类、单宁类、固定油、脂肪、蛋白质等多种生物活性化合物,其中白丹素是最重要的生物活性化合物。它具有抗炎、抗菌、抗癌、抗溃疡、抗糖尿病等广泛的药物活性。对其药理活性进行了若干研究。本综述的目的是提供一个全面的了解p。泽兰草的化学成分及药理作用。
{"title":"A Comprehensive Review on Anti-Inflammatory Activity of The Traditional Plants Plumbago zeylanica(Chitra)","authors":"A. Yadav, Avadh Biharee, Ramesh Kumar, Patel, L. Chaudhari, Dheeraj Dubey","doi":"10.25166/ijppr.2021.v22i01.14","DOIUrl":"https://doi.org/10.25166/ijppr.2021.v22i01.14","url":null,"abstract":"Medicinal plants have long been utilised as a source of\u0000medicine and are in high demand throughout the world.\u0000They've been around for a long time, and they've been\u0000utilised to cure and prevent ailments. Plumbago zeylanica is\u0000a medicinal plant that is frequently utilised for its medicinal\u0000properties. It contains several bioactive compounds like\u0000napthoquinones, flavonoids, alkaloids, glycosides, steroids,\u0000tri-terpenoids, tannins, fixed oils, fats, proteins, etc. among\u0000all plumbagin is most important bioactive compounds. It\u0000possesses wide range of pharmaceutical activities such as\u0000anti-inflammatory, antimicrobial, anti-cancer, anti-ulcer,\u0000antidiabetic etc. Several investigations on its\u0000pharmacological activity have been conducted. The goal of\u0000this review is to provide a comprehensive understanding of\u0000P. zeylanica's chemical composition and pharmacological\u0000action.","PeriodicalId":92533,"journal":{"name":"International journal of pharmacy and pharmaceutical research","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43127159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Formulation and Evaluation of Floating Tablets of Ranitidine Hydrochloride with Liquorice as Natural Ulcer Protective Agent 甘草作为天然溃疡保护剂的盐酸雷尼替丁漂浮片的处方及评价
Pub Date : 2019-12-30 DOI: 10.25166/ijppr.2020.v17i01.04
Poonam Sansarwal, Sunaina Sharma, Richa Ohri
The concurrent trend in pharmaceutical evolution accentuates the effectiveness of floating tablets over conventional dosage form. Furthermore, it facilitates site-specificity, controlled release and is irrespective of gastric emptying. The present study was carried out to enhance the bioavailability of Ranitidine HCl, a floating dosage form with controlled release. Ranitidine HCl has a narrow absorption window in the gastrointestinal tract; therefore its absorption was improved by modifying the dosage form. The action potential of a drug is synergized by combining it with a natural ulcer protective agent that is liquorice. The tablets were prepared by wet granulation method. The batches were formulated using a different ratio of HPMC K15 and Carbopol. It ensures the effectiveness of the formulation variable on drug release and buoyancy property of the delivery system. The prepared formulations show significant results obtained by pharmacopoeial quality control tests. In-vitro dissolution study was also performed to check whether the ratio of polymers was optimum for controlled release or not. The present study suggests that the Ranitidine HCl and liquorice together are well compatible with each other. However, the effectiveness of the drug combination partially depends upon the ratio of polymers. Poonam Sansarwal, Sunaina Sharma, Richa Ohri 1. Himalayan Institute of Pharmacy, Kala-amb, Himachal Pradesh, India-173030 2. LBR college of Pharmacy, Panchkula, Haryana, India-134109 Submission: 23 November 2019 Accepted: 29 November 2019 Published: 30 December 2019 www.ijppr.humanjournals.com Citation: Richa Ohri et al. Ijppr.Human, 2019; Vol. 17 (1): 38-59. 39 INTRODUCTION Most of the medicaments are administered by oral route due to high patient compliance. However, the ideal drug delivery system needs two basic components. Firstly, the drug should be delivered at a predetermined rate for a prolonged time, for the prevention of fluctuation in plasma concentration. Secondly, the drug should bind solely to its selective receptor. Unfortunately, available systems do not relay such kind of properties. Hence the time demands modification in conventional dosage form for the betterment of therapeutic efficacy and drug safety [1, 2]. Manufacturing sustained release or controlled release drug delivery systems can help overcome the above-mentioned drawbacks. For instance, the major risk factor is decreased bioavailability due to the narrow absorption window. So far several new approaches such as bioadhesive, floating, swelling-activated drug delivery systems were made to lengthen the Gastric Retention Time (GRT)[3]. The existing trend in pharmaceutical evolution accentuates the effectiveness of floating tablets over conventional dosage form. On inference, it facilitates site-specificity, controlled release and is irrespective of gastric emptying[4, 5].Floating tablet tending to keep afloat for several hours. The buoyancy of tablets is achieved by gas generating
盐酸雷尼替丁样品溶液的制备主要储备溶液是通过将相当于100 mg的112 mg纯盐酸雷尼替定溶解在100 ml SGF pH 1.2中以获得1mg/ml的浓度来制备的。从一次储备溶液中吸取5ml二次储备溶液,并转移到50ml容量瓶中,使用SGF pH 1.2将最终体积调至50ml。从二次储备液中制备浓度为20μg/ml、40μg/ml、60μg/ml、80μg/ml、100μg/ml的样品溶液。使用SGF pH 1.2作为空白溶液,通过UV分光光度计(Labindia Analytical)在314nm处测量吸光度。根据浓度(x轴)和吸光度(y轴)绘制校准曲线。相容性研究:采用傅立叶变换红外光谱法对药物甘草和聚合物进行了研究,并对其相容性进行了解释。www.ijppr.humanjournals.com引文:Richa Ohri等人ijppr。人类,2019;第17卷(1):38-59。41湿法制粒法制备片剂:称量准确量的盐酸雷尼替丁、甘草,分别通过40#目筛,然后充分混合。在将这些聚合物即HPMC K15和Carbopol以所需量混合到药物混合物中之后。然后在混合物中加入碳酸氢钠和柠檬酸并充分混合,它们作为泡腾剂保持片剂的漂浮特性。在95%乙醇(造粒剂)的帮助下制备湿质量的混合物,并通过孔径为10#的筛网进行湿筛。颗粒的干燥在40°C的热风炉中使用托盘干燥技术进行。将干颗粒通过具有40#筛孔的筛网进行筛选,并且允许约15%的细粒保留在颗粒中。最后,将干燥的颗粒与硬脂酸镁和滑石在八角形搅拌器中混合。然后使用caimach压缩机对混合物进行压缩。表1:不同批次一片片剂的成分批次代码成分(数量,mg)F1 F2 F3 F4 F5雷尼替丁HCl 168 168 168 168甘草50 50 50 50 HPMC K15 25 50 50 10 Carbopol 50 50 50柠檬酸10 10 10 10碳酸氢钠50 60 70 80 90滑石5 5 5 5 55 5硬脂酸镁7 7 7 7 8 7 7 7压缩前评估:[11,12]1。堆积密度和振实密度2。休止角3。压缩指数4。Hausner比率www.ijppr.humanjournals.com引用:Richa Ohri等人ijppr。人类,2019;第17卷(1):38-59。42堆积密度:称量20克颗粒并倒入量筒中,测量堆积体积。堆积密度的计算公式为:堆积密度=(颗粒质量/堆积体积)x100敲击密度:敲击量筒以获得恒定体积,然后使用表达式计算敲击密度:轻敲密度=(粒子质量/颗粒敲击体积)x100.休止角(): 使用漏斗形成一堆混合物,然后测量混合物的高度和半径 = h/r = tan(h/r)其中 = 休止角h=混合物堆高度r=混合物堆半径压缩指数和豪斯纳比:通过将堆积密度和振实密度代入公式来确定:压缩指数=(振实密度-堆积密度/振实密度)x100豪斯纳比=振实密度/堆积密度片剂评价:制备的片剂基于以下参数:www.ijppr.humanjournals.com引用:Richa Ohri等人ijppr。人类,2019;第17卷(1):38-59。43漂浮片剂的理化评价[13-15]重量变化从批次中取出20片,测量其重量,然后测量平均重量。然后计算与平均体重的偏差,并将其与IP 2014的体重变化限值进行比较。直径和厚度:使用游标卡尺测量。脆性:采用罗氏脆性测定仪测定脆性。选择20片片剂并称重(Winitial),并转移到friabilator中。将脆性分子筛以25rpm旋转4分钟。然后观察片剂的最终重量,即Wfinal。使用以下表达式计算脆性百分比:%脆性=(Winitial-Wfinal/Winitial)×100硬度:使用孟山都硬度计测定片剂的硬度(Kg/cm)。溶胀指数:将片剂置于模拟胃液中测定。在不同的时间间隔观察片剂的溶胀重量。然后使用以下公式计算溶胀指数:溶胀指数=(湿重干重/干重)X100体外浮力研究:评估所有批次盐酸雷尼替丁的漂浮滞后时间和总漂浮时间。为了确定漂浮滞后时间,从每批中随机选择一片片剂,并将其保存在含有模拟胃液(pH 1.2)的100ml烧杯中。
{"title":"Formulation and Evaluation of Floating Tablets of Ranitidine Hydrochloride with Liquorice as Natural Ulcer Protective Agent","authors":"Poonam Sansarwal, Sunaina Sharma, Richa Ohri","doi":"10.25166/ijppr.2020.v17i01.04","DOIUrl":"https://doi.org/10.25166/ijppr.2020.v17i01.04","url":null,"abstract":"The concurrent trend in pharmaceutical evolution accentuates the effectiveness of floating tablets over conventional dosage form. Furthermore, it facilitates site-specificity, controlled release and is irrespective of gastric emptying. The present study was carried out to enhance the bioavailability of Ranitidine HCl, a floating dosage form with controlled release. Ranitidine HCl has a narrow absorption window in the gastrointestinal tract; therefore its absorption was improved by modifying the dosage form. The action potential of a drug is synergized by combining it with a natural ulcer protective agent that is liquorice. The tablets were prepared by wet granulation method. The batches were formulated using a different ratio of HPMC K15 and Carbopol. It ensures the effectiveness of the formulation variable on drug release and buoyancy property of the delivery system. The prepared formulations show significant results obtained by pharmacopoeial quality control tests. In-vitro dissolution study was also performed to check whether the ratio of polymers was optimum for controlled release or not. The present study suggests that the Ranitidine HCl and liquorice together are well compatible with each other. However, the effectiveness of the drug combination partially depends upon the ratio of polymers. Poonam Sansarwal, Sunaina Sharma, Richa Ohri 1. Himalayan Institute of Pharmacy, Kala-amb, Himachal Pradesh, India-173030 2. LBR college of Pharmacy, Panchkula, Haryana, India-134109 Submission: 23 November 2019 Accepted: 29 November 2019 Published: 30 December 2019 www.ijppr.humanjournals.com Citation: Richa Ohri et al. Ijppr.Human, 2019; Vol. 17 (1): 38-59. 39 INTRODUCTION Most of the medicaments are administered by oral route due to high patient compliance. However, the ideal drug delivery system needs two basic components. Firstly, the drug should be delivered at a predetermined rate for a prolonged time, for the prevention of fluctuation in plasma concentration. Secondly, the drug should bind solely to its selective receptor. Unfortunately, available systems do not relay such kind of properties. Hence the time demands modification in conventional dosage form for the betterment of therapeutic efficacy and drug safety [1, 2]. Manufacturing sustained release or controlled release drug delivery systems can help overcome the above-mentioned drawbacks. For instance, the major risk factor is decreased bioavailability due to the narrow absorption window. So far several new approaches such as bioadhesive, floating, swelling-activated drug delivery systems were made to lengthen the Gastric Retention Time (GRT)[3]. The existing trend in pharmaceutical evolution accentuates the effectiveness of floating tablets over conventional dosage form. On inference, it facilitates site-specificity, controlled release and is irrespective of gastric emptying[4, 5].Floating tablet tending to keep afloat for several hours. The buoyancy of tablets is achieved by gas generating","PeriodicalId":92533,"journal":{"name":"International journal of pharmacy and pharmaceutical research","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47589991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Holistic Treatment for ALS Reveals Possible Mechanism and Therapeutic Potential. 评估ALS的整体治疗揭示了可能的机制和治疗潜力。
Pub Date : 2017-12-01 Epub Date: 2017-12-30
Andrea Lavado, Xiufang Guo, Alec St Smith, Nesar Akanda, Candace Martin, Yunqing Cai, Dan Elbrecht, My Tran, Jean-Paul Bryant, Alisha Colon, Christopher J Long, Stephen Lambert, Dave Morgan, James J Hickman

There has been a tremendous amount of research into the causes of Amyotrophic Lateral Sclerosis (ALS), but yet very few treatment options beyond amelioration of symptoms. A holistic approach has shown anecdotal evidence of slowing disease progression and this treatment, known as the Deanna protocol (DP), postulates that ALS is a metabolic disease caused by glutamate that induces toxicity. In this study, glutamate exposure to human motoneurons was investigated and found not to significantly affect cell viability or electrophysiological properties. However, varicosities were observed in axons suggestive of transport impairment that was dose dependent for glutamate exposure. Surprisingly, a subset of the components of the DP eliminated these varicosities. To verify this finding a human SOD1 patient-derived iPSC line was examined and significant numbers of varicosities were present without glutamate treatment, compared to the iPSC control, indicating the possibility of a common mechanism despite different origins for the varicosities. Importantly, the DP ameliorated these varicosities by over 70% in the patient derived cells as well. These results are consistent with much of the literature on ALS and give hope for treatment not only for arresting disease progression using compounds considered safe but also the potential for restoration of function.

对肌萎缩侧索硬化症(ALS)的病因进行了大量研究,但除了改善症状外,几乎没有其他治疗选择。一种全面的方法显示了减缓疾病进展的轶事证据,这种被称为Deanna方案(DP)的治疗方法假设ALS是一种由谷氨酸引起的代谢性疾病,会引起毒性。在这项研究中,研究了谷氨酸暴露于人类运动神经元,发现谷氨酸不会显著影响细胞活力或电生理特性。然而,在轴突中观察到静脉曲张,提示谷氨酸暴露的剂量依赖性运输损伤。令人惊讶的是,DP的一个子组分消除了这些静脉曲张。为了验证这一发现,对人SOD1患者衍生的iPSC系进行了检查,与iPSC对照组相比,在没有谷氨酸治疗的情况下存在大量静脉曲张,这表明尽管静脉曲张的起源不同,但可能存在共同的机制。重要的是,DP在患者来源的细胞中也改善了70%以上的静脉曲张。这些结果与许多关于ALS的文献一致,并为使用被认为安全的化合物进行治疗带来了希望,不仅可以阻止疾病进展,还可以恢复功能。
{"title":"Evaluation of Holistic Treatment for ALS Reveals Possible Mechanism and Therapeutic Potential.","authors":"Andrea Lavado,&nbsp;Xiufang Guo,&nbsp;Alec St Smith,&nbsp;Nesar Akanda,&nbsp;Candace Martin,&nbsp;Yunqing Cai,&nbsp;Dan Elbrecht,&nbsp;My Tran,&nbsp;Jean-Paul Bryant,&nbsp;Alisha Colon,&nbsp;Christopher J Long,&nbsp;Stephen Lambert,&nbsp;Dave Morgan,&nbsp;James J Hickman","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>There has been a tremendous amount of research into the causes of Amyotrophic Lateral Sclerosis (ALS), but yet very few treatment options beyond amelioration of symptoms. A holistic approach has shown anecdotal evidence of slowing disease progression and this treatment, known as the Deanna protocol (DP), postulates that ALS is a metabolic disease caused by glutamate that induces toxicity. In this study, glutamate exposure to human motoneurons was investigated and found not to significantly affect cell viability or electrophysiological properties. However, varicosities were observed in axons suggestive of transport impairment that was dose dependent for glutamate exposure. Surprisingly, a subset of the components of the DP eliminated these varicosities. To verify this finding a human SOD1 patient-derived iPSC line was examined and significant numbers of varicosities were present without glutamate treatment, compared to the iPSC control, indicating the possibility of a common mechanism despite different origins for the varicosities. Importantly, the DP ameliorated these varicosities by over 70% in the patient derived cells as well. These results are consistent with much of the literature on ALS and give hope for treatment not only for arresting disease progression using compounds considered safe but also the potential for restoration of function.</p>","PeriodicalId":92533,"journal":{"name":"International journal of pharmacy and pharmaceutical research","volume":"11 1","pages":"348-374"},"PeriodicalIF":0.0,"publicationDate":"2017-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326589/pdf/nihms958630.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36858703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International journal of pharmacy and pharmaceutical research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1